Economiic Home Method Watch Market RSI Search

Synaptogenix, Inc. SNPX

Sector:

Healthcare

Industry:

Biotechnology

Description:

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.
Synaptogenix, Inc. website

Recent Quarter:

2024-11-12

Upcoming Quarter:

N/A

Annual Reports

Date2024-04-01
Revenue 0
Net Income -6,038,504
EPS -29.56
Basic Shares 466,076
Diluted Shares 466,076
Report Link
Date2023-03-21
Revenue 0
Net Income -5,458,067
EPS -0.78
Basic Shares 6,989,200
Diluted Shares 6,989,200
Report Link
Date2022-03-29
Revenue 0
Net Income -12,604,087
EPS -2.51
Basic Shares 5,015,100
Diluted Shares 5,015,100
Report Link
Date2021-03-30
Revenue 0
Net Income -14,249,984
EPS -11.33
Basic Shares 1,257,579
Diluted Shares 1,257,579
Report Link
Date2019-12-31
Revenue 0
Net Income -14,756,043
EPS -2.48
Basic Shares 5,947,666
Diluted Shares 5,947,666
Report Link
Date2018-12-31
Revenue 0
Net Income -11,022,286
EPS -46.33
Basic Shares 237,906
Diluted Shares 237,906
Report Link

Annual Ratios

Date2023-12-31
PE -0.52
Dividend Yield 20.23
Payout Ratio: -10.616%
Date2022-12-31
PE -37.14
Dividend Yield 0.06
Payout Ratio: -2.123%
Date2021-12-31
PE -84.65
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -13.24
Dividend Yield 10.60
Payout Ratio: -140.375%
Date2019-12-31
PE -34.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -1.86
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-12
Revenue 0
Net Income 6,048,738
EPS 4.58
Basic Shares 1,320,000
Diluted Shares 1,320,000
Report Link
Date2024-08-14
Revenue 0
Net Income -1,273,309
EPS -1.18
Basic Shares 1,206,600
Diluted Shares 1,206,600
Report Link
Date2024-05-15
Revenue 0
Net Income -206,699
EPS -0.2
Basic Shares 1,036,700
Diluted Shares 1,036,700
Report Link
Date2024-04-01
Revenue 10,274
Net Income -995,969
EPS -1.03
Basic Shares 963,585
Diluted Shares 963,585
Report Link
Date2023-11-14
Revenue 0
Net Income 763,203
EPS 0.0713
Basic Shares 10,702,900
Diluted Shares 10,702,900
Report Link
Date2023-08-14
Revenue 0
Net Income -4,093,954
EPS -0.56
Basic Shares 7,361,300
Diluted Shares 7,361,300
Report Link
Date2023-05-15
Revenue 0
Net Income -1,445,710
EPS -0.19
Basic Shares 7,501,400
Diluted Shares 7,501,400
Report Link
Date2023-03-21
Revenue 0
Net Income 4,482,345
EPS 0.63
Basic Shares 6,930,880
Diluted Shares 6,930,880
Report Link
Date2022-11-10
Revenue 0
Net Income -3,167,206
EPS -0.45
Basic Shares 6,988,000
Diluted Shares 6,988,000
Report Link
Date2022-08-05
Revenue 0
Net Income -3,796,391
EPS -0.55
Basic Shares 6,959,400
Diluted Shares 6,959,400
Report Link
Date2022-05-13
Revenue 0
Net Income -3,282,532
EPS -0.47
Basic Shares 6,939,200
Diluted Shares 6,939,200
Report Link
Date2022-03-29
Revenue 0
Net Income -4,236,045
EPS -0.68
Basic Shares 6,196,600
Diluted Shares 6,196,600
Report Link
Date2021-11-12
Revenue 0
Net Income -2,926,933
EPS -0.47
Basic Shares 6,196,600
Diluted Shares 6,196,600
Report Link
Date2021-08-13
Revenue 0
Net Income -2,293,842
EPS -0.58
Basic Shares 3,971,200
Diluted Shares 3,971,200
Report Link
Date2021-05-14
Revenue 0
Net Income -3,154,377
EPS -1.06
Basic Shares 2,969,000
Diluted Shares 2,969,000
Report Link
Date2021-03-30
Revenue 0
Net Income -2,964,118
EPS -0.75
Basic Shares 3,971,200
Diluted Shares 3,971,200
Report Link
Date2020-12-23
Revenue 0
Net Income -4,269,609
EPS -3.4
Basic Shares 1,257,579
Diluted Shares 1,257,579
Report Link
Date2020-06-30
Revenue 0
Net Income -2,932,126
EPS -2.33
Basic Shares 1,257,579
Diluted Shares 1,257,579
Report Link
Date2020-03-31
Revenue 0
Net Income -2,537,344
EPS -2.02
Basic Shares 1,257,579
Diluted Shares 1,257,579
Report Link
Date2019-12-31
Revenue 0
Net Income -2,613,563
EPS -2.08
Basic Shares 1,257,579
Diluted Shares 1,257,579
Report Link
Date2019-09-30
Revenue 0
Net Income -3,824,563
EPS -3.04
Basic Shares 1,257,579
Diluted Shares 1,257,579
Report Link

Quarterly Ratios

Date2024-09-30
PE 0.16
Dividend Yield 23.85
Payout Ratio: 15.721%
Date2024-06-30
PE -0.98
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -5.76
Dividend Yield 55.04
Payout Ratio: -1267.142%
Date2023-12-31
PE -1.64
Dividend Yield 0.00
Payout Ratio: -0.005%
Date2023-09-30
PE 38.57
Dividend Yield 0.00
Payout Ratio: 0.006%
Date2023-06-30
PE -10.42
Dividend Yield 0.38
Payout Ratio: -15.659%
Date2023-03-31
PE -25.94
Dividend Yield 0.18
Payout Ratio: -18.404%
Date2022-12-31
PE 11.21
Dividend Yield 0.06
Payout Ratio: 2.585%
Date2022-09-30
PE -92.39
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -59.46
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -102.26
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -77.80
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -131.52
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -106.58
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -49.89
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -50.24
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -6.33
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -9.22
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -10.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -10.35
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-09-30
PE -7.07
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

48.32

Price:

$2.65

Market Cap:

3,593,722

EPS TTM:

2.17

PE Ratio:

0.98

PEPSG:

NaN

Fwd PE:

NaN

Volume:

29,600

2 Year Price Change

0.016

Index 2 Year Price Change

1.497

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: